|
[1]VALENTI L, DONGIOVANNI P, FARGION S.Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease[J].World J Gastroenterol, 2012, 18 (29) :3782-3786.
|
|
[2]NELSON JE, WILSON L, BRUNT EM, et al.Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease[J].Hepatology, 2011, 53 (2) :448-457.
|
|
[3]KOWDLEY KV, BELT P, WILSON LA, et al.Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease[J].Hepatology, 2012, 55 (1) :77-85.
|
|
[4]MALIKEN BD, NELSON JE, KLINTWORTH HM, et al.Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease[J].Hepatology, 2013, 57 (5) :1806-1813.
|
|
[5]VALENTI L, FRACANZANI AL, BUGIANESI E, et al.HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease[J].Gastroenterology, 2012, 138 (3) :905-912.
|
|
[6]MELI R, MATTACE RASO G, LRACE C, et al.High fat diet induces liver steatosis and early dysregulation of iron metabolism in rats[J].PLoS One, 2013, 8 (6) :e66570.
|
|
[7]SANTOS PC, KRIEGER JE, PEREIRA AC.Molecular diagnostic and pathogenesis of hereditary hemochromatosis[J].Int J Mol Sci, 2012, 13 (2) :1497-1511.
|
|
[8]MOYER TP, HIGHSMITH WE, SMYRK TC, et al.Hereditary hemochromatosis:laboratory evaluation[J].Clin Chim Acta, 2011, 412 (17-18) :1485-1492.
|
|
[9]NELSON JE, KLINTWORTH H, KOWDLEY KV.Iron metabolism in Nonalcoholic fatty liver disease[J].Curr Gastroenterol Rep, 2012, 14 (1) :8-18.
|
|
[10]O’BRIEN J, POWELL LW.Non-alcoholic fatty liver disease:is iron relevant?[J]Hepatol Int, 2012, 6 (1) :332-341.
|
|
[11]HAAP M, MACHANN J, von FRIEDEBURG C, et al.Insulin sensitivity and liver fat:role of iron load[J].J Clin Endocrinol Metab, 2011, 96 (6) :e958-e961.
|
|
[12]VALENTI L, DONGIOVANNI P, FRACANZANI AL, et al.Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis[J].Dig Liver Dis, 2003, 35 (3) :172-178.
|
|
[13]NELSON JE, BRUNT EM, KOWDLEY KV.Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations[J].Hepatology, 2012, 56 (5) , 1730-1740.
|
|
[14]TSUCHIYA H, EBATA Y, SAKABE T, et al.High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice[J].Metabolism, 2013, 62 (1) :62-69.
|
|
[15]YONEDA M, NOZAKI Y, ENDO H, et al.Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation[J].Dig Dis Sci, 2010, 55 (3) :808-814.
|
|
[16]FUJITA N, TAKEI Y.Iron overload in nonalcoholic steatohepatitis[J].Adv Clin Chen, 2011, 55:105-132.
|
|
[17]SUMIDA Y, YOSHIKAWA T, OKANOUE T.Role of hepatic iron in non-alcoholic steatohepatitis[J].Hepatol Res, 2009, 39 (3) :213-222.
|
|
[18]DONGIOVANNI P, FRACANZANI AL, FARGION S, et al.Iron in fatty liver and in the metabolic syndrome:a promising therapeutic target[J].J Hepatol, 2011, 55 (4) :920-932.
|
|
[19]SORRENTINO P, D’ANGELO S, FERBO U, et al.Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis[J].J Heptol, 2009, 50 (2) :351-357.
|
|
[20]VALENTI L, SWINKELS DW, BURDICK L, et al.Serum ferritin level are associated with vascular damage in patients with nonalcoholic fatty liver disease[J].Nutr Metab Cardiovasc Dis, 2011, 21 (8) :568-575.
|
|
[21]AHMED U, LATHAM PS, OATES PS.Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis[J].World J Gastroenterol, 2012, 18 (34) :4651-4658.
|
|
[22]TAN TC, CRAWFORD DH, JASKOWSKI LA, et al.Altered lipid metabolism in HFE-knockout mice promotes severe NAFLD and early fibrosis[J].Am J Physiol Gastrointest Liver Physiol, 2011, 301 (5) :g865-g876.
|
|
[23]SUMIDA Y, YONEDA M, HYOGO H, et al.A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen7S for predicting steatohepatitis in nonalcoholic fatty liver disease[J].J Gastroenterol, 2011, 46 (2) :257-268.
|
|
[24]MANOUSOU P, KALAMBOKIS G, GRILLO F, et al.Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients[J].Liver Int, 2011, 31 (5) :730-739.
|
|
[25]DONGIOVANNI P, VALENTI L, LUDOVICA FRACANZANI A, et al.Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver[J].Am J Pathol, 2008, 172 (3) :738-747.
|
|
[26]FACCHINI FS, HUA NW, STOOHS RA.Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease[J].Gastroenterology, 2002, 122 (4) :931-939.
|
|
[27]FERNANDEZ-REAL JM, PENARROJA G, CASTRO A, et al.Blood letting in high-ferritin type 2 diabetes:effects on insulin sensitivity and beat-cell function[J].Diabetes, 2002, 51 (4) :1000-1004.
|
|
[28]VALENTI L, FRACANZANI AL, DONGIOVANNI P, et al.Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia:evidence from a case-control study[J].Am J Gastroenterol, 2007, 102 (6) :1251-1258.
|
|
[29]VALENTI L, MOSCATIELLO S, VANNI E, et al.Venesection for nonalcolholic fatty liver disease unresponsive to lifestyle counselling-a propensity score-adjusted observational study[J].QJM, 2011, 104 (2) :141-149.
|
|
[30] VALENTI L, SWINKELS DW, BURDICK L, et al.Serum ferritin level are associated with vascular damage in patients with nonalcoholic fatty liver disease[J].Nutr Metab Cardiovasc Dis, 2011, 21 (8) :568-575.
|
|
[31]BEATON MD, CHAKRABARTI S, LEVSTIK M, et al.Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther, 2013, 37 (7) :720-729.
|
DownLoad: